PNV.AX · POLYNOVO LIMITED
Australia · RS rating 44 · As of 2026-10-14
| Price | 0.92 AUD |
|---|---|
| 1-day change | +1.1% |
| RS rating (overall / 1M / 3M / 12M) | 44 / 47 / 44 / 39 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 24 / 11 / 14 |
| Industry group (rank) | Medical-Biomed/Biotech (–) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +34.6% |
| Market cap (USD) | $449.5M |